Netherlands: Onward Medical prices IPO at €12.75

Netherlands-headquartered Onward Medical, a medical technology company developing and commercialising therapies to enable functional recovery for people with spinal cord injury, has priced its IPO in the middle of the marketing range at €12.75. Some 5.9 million new shares were placed, raising €75.2m (US$87.5m). There is a 15% over allotment option. Shares were listed on…

You must be a HMI Subscriber to view this content.

Subscribe Now »